Dailypharm Live Search Close

Stock-out Cytotec and Livalo V supply to resume from January

By Kim, Min-Gun | translator Byun Kyung A

19.12.11 12:01:28

가나다라 0
Long-term users consider switching out, companies say manufacturing plant delay is to blame



Some doses of Pfizer Korea’s stomach ulcer preventing drug Cytotec (misoprostol) has run out of stock and the company say the supply would resume around early next year.

Sources from the pharmaceutical industry reported on Dec. 11 that there is a temporary shortage on 200 mcg 120 BTL dose of Cytotec.

Pin pointing at the delay in manufacturing plant schedule, Pfizer stated “The supply would be provided as soon as possible”.

Pfizer predicts the supply would resume from early January next year. The company explained “We are closely following up with the manufacturing plant on providing the supply”.

Cytotec’s indication has been approved for reducing th

Kim, Min-Gun(kmg@dailypharm.com)
If you want to see the full article, please JOIN US (click)